Please enable JavaScript to continue using this application.

Compare $AKTS vs $MGTX | Chartloom

Compare

$AKTS vs $MGTX

Aktis Oncology Inc · MeiraGTx Holdings PLC

AKTS

Aktis Oncology Inc

MGTX

MeiraGTx Holdings PLC

Compare $AKTS vs $MGTX

Comparing Aktis Oncology Inc and MeiraGTx Holdings PLC

AKTSAktis Oncology Inc

MGTXMeiraGTx Holdings PLC

AKTSAktis Oncology Inc

Market cap

$969M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

99.47x

Rev growth (TTM)

49.9%

YTD performance

-19.0%

52W performance

18688.8%

FCF yield

-12.6%

MGTXMeiraGTx Holdings PLC

Market cap

$990M

P/E (TTM)

12.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

27.71x

Rev growth (TTM)

948.3%

YTD performance

36.9%

52W performance

29.4%

FCF yield

1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTS

MGTX

Detailed metrics comparison

AKTS

Aktis Oncology Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

AKTS$969M

MGTX$990M

Enterprise Value

AKTS$887M

MGTX$947M

Price

AKTS$18.15

MGTX$10.69

P/E Ratio

AKTSN/A

MGTX12.70x

P/S Ratio

AKTS73.94x

MGTX2.49x

EV/Sales

AKTS67.65x

MGTX2.38x

EV/EBITDA

AKTS0.00x

MGTX4.63x

P/B Ratio

AKTS2.12x

MGTX4.81x

P/FCF Ratio

AKTSN/A

MGTX94.58x

EV/FCF

AKTS-7.29x

MGTX90.47x

PEG Ratio

AKTSN/A

MGTXN/A

Forward P/E (NTM)

AKTSN/A

MGTXN/A

Forward P/S (NTM)

AKTS99.47x

MGTX27.71x

Revenue (TTM)

AKTS$13M

MGTX$398M

Revenue Growth (YoY)

AKTS49.9%

MGTX948.3%

Forward Rev Growth

AKTS-9.8%

MGTX-75.7%

Gross Margin (TTM)

AKTS0.0%

MGTX97.9%

Operating Margin (TTM)

AKTS0.0%

MGTX46.3%

EBITDA Margin (TTM)

AKTS-934.0%

MGTX49.3%

Net Margin (TTM)

AKTS-810.2%

MGTX19.9%

FCF Margin (TTM)

AKTS-928.1%

MGTX2.6%

Net Income (TTM)

AKTS$-106M

MGTX$79M

FCF (TTM)

AKTS$-122M

MGTX$10M

EPS (TTM)

AKTS-$1.92

MGTX$0.84

ROE (TTM)

AKTS-3080.0%

MGTX74.6%

ROA (TTM)

AKTS-2531.0%

MGTX29.4%

ROIC (TTM)

AKTS-3080.0%

MGTX50.9%

Cash

AKTS$82M

MGTX$143M

Debt

AKTS$0

MGTX$100M

Net Cash/Debt

AKTS$82M

MGTX$43M

Current Ratio (TTM)

AKTS16.33x

MGTX3.76x

Quick Ratio (TTM)

AKTS16.10x

MGTX3.69x

Debt/Equity (TTM)

AKTS0.00x

MGTX0.46x

Debt/Assets (TTM)

AKTS0.0%

MGTX0.0%

Interest Coverage (TTM)

AKTSN/A

MGTXN/A

Net Debt/EBITDA (TTM)

AKTS0.00x

MGTX0.00x

Beta

AKTS160.56

MGTX1.05

52W Performance

AKTS18688.8%

MGTX29.4%

YTD Performance

AKTS-19.0%

MGTX36.9%

% from 52W High

AKTS-46.9%

MGTX-30.4%

% from 52W Low

AKTS907400.0%

MGTX61.5%

Asset Turnover (TTM)

AKTS0.03x

MGTX1.48x

FCF Yield (TTM)

AKTS-12.6%

MGTX1.1%

Earnings Yield (TTM)

AKTS-11.0%

MGTX8.0%

Dividend Yield (TTM)

AKTSN/A

MGTXN/A

Rule of 40

AKTS-878.2

MGTX951.0

EV/GP/RG

AKTSN/A

MGTXN/A

Ticker research

View AKTS research View MGTX research

Metric	AKTS Aktis Oncology Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$969M	$990M
Enterprise Value	$887M	$947M
Price	$18.15	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	73.94x	2.49x
EV/Sales	67.65x	2.38x
EV/EBITDA	0.00x	4.63x
P/B Ratio	2.12x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-7.29x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	99.47x	27.71x
Revenue & Growth
Revenue (TTM)	$13M	$398M
Revenue Growth (YoY)	49.9%	948.3%
Forward Rev Growth	-9.8%	-75.7%
Profitability
Gross Margin (TTM)	0.0%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	-934.0%	49.3%
Net Margin (TTM)	-810.2%	19.9%
FCF Margin (TTM)	-928.1%	2.6%
Net Income (TTM)	$-106M	$79M
FCF (TTM)	$-122M	$10M
EPS (TTM)	-$1.92	$0.84
ROE (TTM)	-3080.0%	74.6%
ROA (TTM)	-2531.0%	29.4%
ROIC (TTM)	-3080.0%	50.9%
Financial Health
Cash	$82M	$143M
Debt	$0	$100M
Net Cash/Debt	$82M	$43M
Current Ratio (TTM)	16.33x	3.76x
Quick Ratio (TTM)	16.10x	3.69x
Debt/Equity (TTM)	0.00x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	160.56	1.05
52W Performance	18688.8%	29.4%
YTD Performance	-19.0%	36.9%
% from 52W High	-46.9%	-30.4%
% from 52W Low	907400.0%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	1.48x
FCF Yield (TTM)	-12.6%	1.1%
Earnings Yield (TTM)	-11.0%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-878.2	951.0
EV/GP/RG	N/A	N/A
Ticker research	View AKTS research	View MGTX research

Valuation

P/E Ratio

MGTX

12.70x

P/S Ratio

MGTX

2.49x

AKTS

73.94x

EV/FCF

AKTS

-7.29x

MGTX

90.47x

Growth & revenue

Revenue Growth TTM

MGTX

948.3%

AKTS

49.9%

Forward Revenue Growth

AKTS

-9.8%

MGTX

-75.7%

Profitability & performance

Gross Margin

MGTX

97.9%

AKTS

0.0%

ROE

MGTX

74.6%

AKTS

-3080.0%

FCF Yield %

MGTX

1.1%

AKTS

-12.6%

52-Week Performance

AKTS

18688.8%

MGTX

29.4%

Detailed metrics comparison

AKTS

Aktis Oncology Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

AKTS$969M

MGTX$990M

Enterprise Value

AKTS$887M

MGTX$947M

Price

AKTS$18.15

MGTX$10.69

P/E Ratio

AKTSN/A

MGTX12.70x

P/S Ratio

AKTS73.94x

MGTX2.49x

EV/Sales

AKTS67.65x

MGTX2.38x

EV/EBITDA

AKTS0.00x

MGTX4.63x

P/B Ratio

AKTS2.12x

MGTX4.81x

P/FCF Ratio

AKTSN/A

MGTX94.58x

EV/FCF

AKTS-7.29x

MGTX90.47x

PEG Ratio

AKTSN/A

MGTXN/A

Forward P/E (NTM)

AKTSN/A

MGTXN/A

Forward P/S (NTM)

AKTS99.47x

MGTX27.71x

Revenue (TTM)

AKTS$13M

MGTX$398M

Revenue Growth (YoY)

AKTS49.9%

MGTX948.3%

Forward Rev Growth

AKTS-9.8%

MGTX-75.7%

Gross Margin (TTM)

AKTS0.0%

MGTX97.9%

Operating Margin (TTM)

AKTS0.0%

MGTX46.3%

EBITDA Margin (TTM)

AKTS-934.0%

MGTX49.3%

Net Margin (TTM)

AKTS-810.2%

MGTX19.9%

FCF Margin (TTM)

AKTS-928.1%

MGTX2.6%

Net Income (TTM)

AKTS$-106M

MGTX$79M

FCF (TTM)

AKTS$-122M

MGTX$10M

EPS (TTM)

AKTS-$1.92

MGTX$0.84

ROE (TTM)

AKTS-3080.0%

MGTX74.6%

ROA (TTM)

AKTS-2531.0%

MGTX29.4%

ROIC (TTM)

AKTS-3080.0%

MGTX50.9%

Cash

AKTS$82M

MGTX$143M

Debt

AKTS$0

MGTX$100M

Net Cash/Debt

AKTS$82M

MGTX$43M

Current Ratio (TTM)

AKTS16.33x

MGTX3.76x

Quick Ratio (TTM)

AKTS16.10x

MGTX3.69x

Debt/Equity (TTM)

AKTS0.00x

MGTX0.46x

Debt/Assets (TTM)

AKTS0.0%

MGTX0.0%

Interest Coverage (TTM)

AKTSN/A

MGTXN/A

Net Debt/EBITDA (TTM)

AKTS0.00x

MGTX0.00x

Beta

AKTS160.56

MGTX1.05

52W Performance

AKTS18688.8%

MGTX29.4%

YTD Performance

AKTS-19.0%

MGTX36.9%

% from 52W High

AKTS-46.9%

MGTX-30.4%

% from 52W Low

AKTS907400.0%

MGTX61.5%

Asset Turnover (TTM)

AKTS0.03x

MGTX1.48x

FCF Yield (TTM)

AKTS-12.6%

MGTX1.1%

Earnings Yield (TTM)

AKTS-11.0%

MGTX8.0%

Dividend Yield (TTM)

AKTSN/A

MGTXN/A

Rule of 40

AKTS-878.2

MGTX951.0

EV/GP/RG

AKTSN/A

MGTXN/A

Ticker research

View AKTS research View MGTX research

Metric	AKTS Aktis Oncology Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$969M	$990M
Enterprise Value	$887M	$947M
Price	$18.15	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	73.94x	2.49x
EV/Sales	67.65x	2.38x
EV/EBITDA	0.00x	4.63x
P/B Ratio	2.12x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-7.29x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	99.47x	27.71x
Revenue & Growth
Revenue (TTM)	$13M	$398M
Revenue Growth (YoY)	49.9%	948.3%
Forward Rev Growth	-9.8%	-75.7%
Profitability
Gross Margin (TTM)	0.0%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	-934.0%	49.3%
Net Margin (TTM)	-810.2%	19.9%
FCF Margin (TTM)	-928.1%	2.6%
Net Income (TTM)	$-106M	$79M
FCF (TTM)	$-122M	$10M
EPS (TTM)	-$1.92	$0.84
ROE (TTM)	-3080.0%	74.6%
ROA (TTM)	-2531.0%	29.4%
ROIC (TTM)	-3080.0%	50.9%
Financial Health
Cash	$82M	$143M
Debt	$0	$100M
Net Cash/Debt	$82M	$43M
Current Ratio (TTM)	16.33x	3.76x
Quick Ratio (TTM)	16.10x	3.69x
Debt/Equity (TTM)	0.00x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	160.56	1.05
52W Performance	18688.8%	29.4%
YTD Performance	-19.0%	36.9%
% from 52W High	-46.9%	-30.4%
% from 52W Low	907400.0%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	1.48x
FCF Yield (TTM)	-12.6%	1.1%
Earnings Yield (TTM)	-11.0%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-878.2	951.0
EV/GP/RG	N/A	N/A
Ticker research	View AKTS research	View MGTX research